Sabatos-Peyton C - Search Results

1

PKCθ links proximal T cell and Notch signaling through localized regulation of the actin cytoskeleton.

Britton GJ, Ambler R, Clark DJ, Hill EV, Tunbridge HM, McNally KE, Burton BR, Butterweck P, Sabatos-Peyton C, Hampton-O'Neil LA, Verkade P, Wülfing ChC, Wraith DC. Britton GJ, et al. Elife. 2017 Jan 31;6:e20003. doi: 10.7554/eLife.20003. Elife. 2017. PMID: 28112644 Free PMC article.

2

Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy.

Burton BR, Britton GJ, Fang H, Verhagen J, Smithers B, Sabatos-Peyton CA, Carney LJ, Gough J, Strobel S, Wraith DC. Burton BR, et al. Nat Commun. 2014 Sep 3;5:4741. doi: 10.1038/ncomms5741. Nat Commun. 2014. PMID: 25182274 Free PMC article.

3

Isolation and characterization of human interleukin-10-secreting T cells from peripheral blood.

Mazza G, Sabatos-Peyton CA, Protheroe RE, Herman A, Campbell JD, Wraith DC. Mazza G, et al. Hum Immunol. 2010 Mar;71(3):225-34. doi: 10.1016/j.humimm.2009.12.003. Epub 2010 Jan 7. Hum Immunol. 2010. PMID: 20034527 Free PMC article.

4

CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire.

Verhagen J, Genolet R, Britton GJ, Stevenson BJ, Sabatos-Peyton CA, Dyson J, Luescher IF, Wraith DC. Verhagen J, et al. Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):E221-30. doi: 10.1073/pnas.1208573110. Epub 2012 Dec 24. Proc Natl Acad Sci U S A. 2013. PMID: 23267099 Free PMC article.

5

Antigen-specific immunotherapy of autoimmune and allergic diseases.

Sabatos-Peyton CA, Verhagen J, Wraith DC. Sabatos-Peyton CA, et al. Curr Opin Immunol. 2010 Oct;22(5):609-15. doi: 10.1016/j.coi.2010.08.006. Epub 2010 Sep 17. Curr Opin Immunol. 2010. PMID: 20850958 Free PMC article. Review.

6

Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells.

Gabrysová L, Nicolson KS, Streeter HB, Verhagen J, Sabatos-Peyton CA, Morgan DJ, Wraith DC. Gabrysová L, et al. J Exp Med. 2009 Aug 3;206(8):1755-67. doi: 10.1084/jem.20082118. Epub 2009 Jul 27. J Exp Med. 2009. PMID: 19635862 Free PMC article.

7

T-bet, a Th1 transcription factor regulates the expression of Tim-3.

Anderson AC, Lord GM, Dardalhon V, Lee DH, Sabatos-Peyton CA, Glimcher LH, Kuchroo VK. Anderson AC, et al. Eur J Immunol. 2010 Mar;40(3):859-66. doi: 10.1002/eji.200939842. Eur J Immunol. 2010. PMID: 20049876 Free PMC article.

8

Prospects for combining targeted and conventional cancer therapy with immunotherapy.

Gotwals P, Cameron S, Cipolletta D, Cremasco V, Crystal A, Hewes B, Mueller B, Quaratino S, Sabatos-Peyton C, Petruzzelli L, Engelman JA, Dranoff G. Gotwals P, et al. Among authors: sabatos peyton c. Nat Rev Cancer. 2017 May;17(5):286-301. doi: 10.1038/nrc.2017.17. Epub 2017 Mar 24. Nat Rev Cancer. 2017. PMID: 28338065 Review.

9

Tim-3 finds its place in the cancer immunotherapy landscape.

Acharya N, Sabatos-Peyton C, Anderson AC. Acharya N, et al. Among authors: sabatos peyton c. J Immunother Cancer. 2020 Jun;8(1):e000911. doi: 10.1136/jitc-2020-000911. J Immunother Cancer. 2020. PMID: 32601081 Free PMC article. Review.

10

Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacy.

Sabatos-Peyton CA, Nevin J, Brock A, Venable JD, Tan DJ, Kassam N, Xu F, Taraszka J, Wesemann L, Pertel T, Acharya N, Klapholz M, Etminan Y, Jiang X, Huang YH, Blumberg RS, Kuchroo VK, Anderson AC. Sabatos-Peyton CA, et al. Oncoimmunology. 2017 Nov 9;7(2):e1385690. doi: 10.1080/2162402X.2017.1385690. eCollection 2018. Oncoimmunology. 2017. PMID: 29308307 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page